Investing.com -- Quantum BioPharma Ltd. (NASDAQ: QNTM) stock fell 5.7% after the company announced it purchased 2,000 shares ...

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to innovative therapies for ...

Biopharmaceutical company Quantum BioPharma said it has acquired 2,000 shares of specialty games and entertainment retailer GameStop in what it calls a strategic investment.

Quantum BioPharma (NASDAQ: QNTM) , a biopharmaceutical company focused on neurodegenerative therapies, has purchased 2,000 shares of GameStop Corp. ( ...

Detailed price information for Quantum Biopharma Ltd (QNTM-Q) from The Globe and Mail including charting and trades.

Quantum BioPharma (QNTM) announced the purchase of 2,000 shares of GameStop (GME) to hold on the Company’s balance sheet as a strategic ...

Speculation is in, conservatism is out as retail investors bid up questionable assets and imaginative financing exploits the ...

Quantum BioPharma is completing a non-brokered private placement of class A multiple voting shares, with a target of up to $600 million in gross proceeds, which will enhance its working capital.

Quantum technology has become an emerging opportunity for artificial intelligence (AI) investors over the last several months ...

Quantum BioPharma retains 100% of the rights to develop similar products or alternative formulations specifically for pharmaceutical and medical uses.

Quantum BioPharma retains 100% of the rights to develop similar products or alternative formulations specifically for pharmaceutical and medical uses.

TORONTO, July 08, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to ...